Investor Summary
Fund Strategy
FUND PERFORMANCE AS OF 31st December 2024
| ANNUALIZED SINCE INCEPTION | QUARTERLY | YTD |
|---|---|---|
| - | -1.6% | 7.3% |
| ANNUALIZED SINCE INCEPTION | QUARTERLY | YTD |
|---|---|---|
| - | -1.6% | 7.3% |
Lansdowne European Fund delivered -1.62% in Q4 2024, outperforming the MSCI Europe benchmark's -2.72% return. The concentrated portfolio of 20-30 European holdings focuses on companies with resilient operating models and attractive valuations. Key contributors included Compass Group, which delivered strong results and guidance supporting the medium-term growth thesis, and Essilor Luxottica, which benefited from Meta partnership developments. Leonardo showed strong operational performance with cost efficiency gains ahead of schedule. Detractors included materials companies Linde and Sika, which faced persistent demand weakness in industrial end markets despite maintaining strong operating leverage. The manager reduced exposure to Michelin due to competitive pressures from Asian imports affecting volume growth. CapGemini faced cyclical IT services weakness but trades at attractive trough valuations. The strategy maintains conviction in holdings' medium-term prospects while selectively adjusting positions based on changing fundamentals. Portfolio positioning reflects patience for end market recovery while capitalizing on temporary weakness in quality names.
Concentrated European equity strategy focused on mid to large cap companies with strong fundamentals, resilient operating models, and attractive valuations that can generate alpha through fundamental analysis of industry capital cycles.
The manager maintains a constructive but selective outlook, focusing on companies with resilient operating models and market share gains despite challenging end markets. They await recovery in end markets while continuing to believe in the medium-term growth potential of their holdings.
| Date | Letter | Tickers | Keywords | Pitches | Quick Takes |
|---|---|---|---|---|---|
| Dec 31 2024 | 2024 Q4 | AHT.L, ASML.AS, CAP.PA, CFR.SW, CPG.L, EL.PA, FER.MC, INF.L, ISP.MI, KBC.BR, LDO.MI, LIN, ML.PA, NOVO-B.CO, REL.L, RTO.L, SAMPO.HE, SHEL.L, SIKA.SW, SU.PA, TEL2B.ST, WTB.L | concentrated, Europe, industrials, materials, value |
CPG.L EL.PA LDO.MI SIKA.SW CAP.PA LIN ML.PA |
Concentrated European equity fund outperformed in Q4 despite challenging industrial end markets. Strong performance from Compass and Essilor offset weakness in materials holdings Linde and Sika. Manager maintains conviction in medium-term growth prospects while selectively trimming weaker positions like Michelin. Strategy focuses on resilient operating models and attractive valuations through industrial cycle. |
| Sep 30 2024 | 2024 Q3 | ASML, CAP.PA, CPG.L, DG.PA, EL.PA, IBE.MC, INF.L, ISP.MI, KBC.BR, LDO.MI, LIN, ML.PA, NESN.SW, NVO, REL.L, RTO.L, SCHN.PA, SHEL.L, SIKA.SW, TELE2.ST | Europe, industrials, infrastructure, Logistics, materials, value |
SIKA.SW FER.MC SGRO.L ML.PA NOVO-B.CO |
Lansdowne European Fund underperformed in Q3 with selective positioning across European mid-large caps. Added Ferrovial for US toll road exposure with pricing power upside. Sees structural improvement in UK logistics via Segro. Trimmed positions in Tele2 after strong run and Leonardo due to aerospace headwinds. Expects construction materials recovery in 2025. |
| Jun 30 2024 | 2024 Q2 | ASML, BOL.ST, CBK.DE, CPG.L, DG.PA, EL.PA, HLMA.L, INF.L, ISP.MI, KBC.BR, LIN, ML.PA, NVO, REL.L, RTO.L, RYA.L, SHEL.L, SIKA.SW, SU.PA, TEL2B.ST | Europe, industrials, technology, Telecom, value |
ASML.AS EL.PA TEL2B.ST |
Lansdowne European Fund delivered 0.80% in Q2, focusing on concentrated positions in quality European companies. Increased ASML on EUV technology leadership and Tele2 on telecom consolidation potential. Reduced French exposure via Vinci due to political risks and trimmed Ryanair on airline demand concerns. Portfolio emphasizes sustainable competitive advantages and structural growth drivers. |
| Mar 31 2024 | 2024 Q1 | AHT.L, ASML, BOL.ST, CAP.PA, CFR.PA, CPG.L, DG.PA, EL.PA, IBE.MC, INF.L, ISP.MI, KBC.BR, LDO.MI, LIN, ML.PA, NESN.SW, NVO.CO, REL.L, RYA.L, SAMPO.HE, SE.PA, SHEL.L, SIK.SW, TELE2-B.ST, UPM.HE | defense, Europe, financials, growth, healthcare, technology, value |
ASML.AS KBC.BR LDO.MI REL.L EL.PA |
Lansdowne European Fund delivered 6.99% in Q1 through concentrated positioning in quality European companies. Key moves included initiating ASML on semiconductor strength, adding to undervalued KBC ahead of rate cuts, and opening EssilorLuxottica on integration completion. Defense spending theme drives Leonardo holding while selective trimming in Iberdrola, Nestle, and Sika reflects disciplined risk management. |
| QUARTER | THEMES | TAGS |
|---|---|---|
| 2024 Q4 |
IndustrialsThe fund holds significant exposure to industrial companies including Compass Group, Leonardo, Schneider Electric, and RELX. These companies are experiencing varying performance driven by operational improvements, cost efficiency programs, and market share gains despite challenging end markets. |
Automation Industrial Services Defense Facilities Management Industrial Distribution |
MaterialsMaterials exposure through Linde and Sika reflects focus on companies with defensive characteristics and market leadership. Both companies face headwinds from weak end markets but demonstrate resilient operating models and continued market share gains. |
Industrial Gases Specialty Chemicals Construction Chemicals | |
| 2024 Q3 |
LogisticsUK logistics demand-supply dynamic is improving structurally with speculative construction starts down 30-40% over the last 12 months and stabilising demand environment. Segro positioned to deliver sustained 3-4% ERV growth with tier-1 assets and attractive development opportunities. |
Real Estate Supply Chain Development Yields |
InfrastructureFerrovial is a first mover in the US managed lane market with critical advantages in traffic flow understanding and toll-road specific construction capabilities. Differentiated analysis suggests tariffs are at a discount to Willingness-To-Pay providing significant pricing runway. |
Toll Roads Transportation Pricing Power Construction | |
GLP1Remain convinced in the GLP-1 story in obesity and adjacent cardio-metabolic areas but note the pipeline is heavily concentrated in few molecules. Adjusting position ahead of CagriSema readout later in the year. |
Obesity Diabetes Pharmaceuticals Pipeline | |
| 2024 Q2 |
SemiconductorsASML maintains monopolistic position in EUV lithography equipment with ROIC >30%. Despite weak Q1 orders of EUR 3.6bn versus Q4's EUR 9.2bn, the weakness is attributed to lumpy order patterns and TSMC's negotiating position. Supply chain feedback on 2nm remains positive, supporting EUV ramp expectations. |
EUV Lithography TSMC 2nm Monopoly |
TelecomTele2 represents best-in-class telecom operator with low capital intensity (12% of sales) and high returns. Temporary headwinds from cost inflation and Huawei equipment replacement are abating. Price increases in mobile and broadband are landing well with 4% MSR growth. Iliad's ownership change should benefit minority shareholders through improved execution and potential consolidation. |
5G Capex MSR Consolidation Iliad | |
| 2024 Q1 |
Defense SpendingEuropean defense spending expected to experience major up-cycle with potential to add over EUR 80bn to regional defense budgets to meet NATO 2% GDP requirement. Leonardo positioned to benefit from increased equipment procurement and electronic content trends. |
Defense NATO Equipment Electronics Europe |
SemiconductorsASML holds monopolistic position in EUV lithography equipment with strong Q4 2023 bookings of EUR 9.5bn. TSMC higher capex guidance supports double digit topline growth backed by credible backlog. |
Lithography EUV TSMC Capex Technology | |
AIRelx well positioned to benefit from incorporating GenAI services within legal tools, analytics and databases. Conservative estimates suggest GenAI could enhance Group organic growth by up to 100bps to structural 7% annually. |
GenAI Legal Analytics Databases Growth |
| Date | Pitch Type | Author | Ticker | Company | Industry | Sub Industry | Bull / Bear | Exchange | Keywords | Action |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2024 | Fund Letters | Lansdowne Partners European Fund | CPG.L | Compass Group PLC | Consumer Discretionary | Hotels, Restaurants & Leisure | Bull | London Stock Exchange | Attractive Multiple, Contract Foodservice, growth algorithm, margin expansion, organic growth, undervalued | Login |
| Dec 31, 2024 | Fund Letters | Lansdowne Partners European Fund | EL.PA | EssilorLuxottica | Health Care | Health Care Equipment & Supplies | Bull | Euronext Paris | innovation, Medium-term Growth, Meta Collaboration, smart glasses, strategic investment, Technology Partnership | Login |
| Dec 31, 2024 | Fund Letters | Lansdowne Partners European Fund | LDO.MI | Leonardo SpA | Industrials | Aerospace & Defense | Bull | Borsa Italiana | Aerospace & Defense, Cost efficiency, EBIT growth, Management Credibility, operational excellence, Strong Results | Login |
| Dec 31, 2024 | Fund Letters | Lansdowne Partners European Fund | SIKA.SW | Sika AG | Materials | Chemicals | Bull | SIX Swiss Exchange | End Market Recovery, market share gains, Medium-term Growth, organic growth, strategic investment, US Recovery | Login |
| Dec 31, 2024 | Fund Letters | Lansdowne Partners European Fund | CAP.PA | Capgemini SE | Information Technology | IT Services | Bull | Euronext Paris | attractive valuation, Cyclical Recovery, IT services, Resilient Operating Model, Trough Earnings, US Recovery | Login |
| Dec 31, 2024 | Fund Letters | Lansdowne Partners European Fund | LIN | Linde plc | Materials | Chemicals | Bull | NYSE | defensive business, double-digit growth, Industrial Gas, Opportunistic Addition, Through-cycle Returns, undervalued | Login |
| Dec 31, 2024 | Fund Letters | Lansdowne Partners European Fund | ML.PA | Michelin | Consumer Discretionary | Auto Components | Bear | Euronext Paris | Asian Competition, competitive dynamics, Price-mix Pressure, Reduced Exposure, Structural Challenges, Volume Decline | Login |
| Sep 30, 2024 | Fund Letters | Lansdowne Partners European Fund | SIKA.SW | Sika AG | Materials | Construction Materials | Bull | SIX Swiss Exchange | construction materials, Cyclical Recovery, High returns, market share, Refurbishment, Renovation, specialty chemicals, Structural Growth | Login |
| Sep 30, 2024 | Fund Letters | Lansdowne Partners European Fund | FER.MC | Ferrovial SE | Industrials | Construction & Engineering | Bull | Madrid Stock Exchange | construction, DOT Relationships, First Mover, infrastructure, Managed Lanes, Pricing power, Toll Roads, Traffic Flow, US market | Login |
| Sep 30, 2024 | Fund Letters | Lansdowne Partners European Fund | SGRO.L | Segro plc | Real Estate | Industrial REITs | Bull | London Stock Exchange | Continental Europe, development, ERV Growth, industrial REIT, Logistics Real Estate, Supply-Demand, UK Property, Vacancy Rates, yield on cost | Login |
| Sep 30, 2024 | Fund Letters | Lansdowne Partners European Fund | ML.PA | Compagnie Générale des Établissements Michelin | Consumer Discretionary | Tires & Rubber | Bear | Euronext Paris | BEV, Brand Superiority, Electric Vehicles, OEM Sales, Raw Materials, Sustainability, Tire Manufacturing, Volume Weakness, Wear Particle Regulation | Login |
| Sep 30, 2024 | Fund Letters | Lansdowne Partners European Fund | NOVO-B.CO | Novo Nordisk A/S | Health Care | Pharmaceuticals | Neutral | Nasdaq Copenhagen | CagriSema, Cardiometabolic, Clinical Readout, Diabetes, GLP-1, Obesity, pharmaceuticals, Pipeline Concentration | Login |
| Jun 30, 2024 | Fund Letters | Lansdowne Partners European Fund | ASML.AS | ASML Holding NV | Information Technology | Semiconductors & Semiconductor Equipment | Bull | Euronext Amsterdam | Equipment, Euv, Lithography, manufacturing, Monopoly, Netherlands, semiconductors, technology | Login |
| Jun 30, 2024 | Fund Letters | Lansdowne Partners European Fund | EL.PA | EssilorLuxottica | Health Care | Health Care Equipment & Supplies | Bull | Euronext Paris | defensive, eyecare, france, healthcare, Italy, Myopia, smart glasses, vertically integrated | Login |
| Jun 30, 2024 | Fund Letters | Lansdowne Partners European Fund | TEL2B.ST | Tele2 AB | Communication Services | Wireless Telecommunication Services | Bull | Nasdaq Stockholm | 5G, capital intensity, consolidation, dividend yield, Sweden, telecommunications, turnaround | Login |
| Mar 31, 2024 | Fund Letters | Lansdowne Partners European Fund | ASML.AS | ASML Holding N.V. | Information Technology | Semiconductors & Semiconductor Equipment | Bull | Euronext Amsterdam | Euv, growth, high-ROIC, lithography equipment, Monopolistic Position, Netherlands, semiconductors, technology | Login |
| Mar 31, 2024 | Fund Letters | Lansdowne Partners European Fund | KBC.BR | KBC Group NV | Financials | Banks | Bull | Euronext Brussels | banking, Belgium, capital requirements, diversified business model, high dividend yield, rate sensitivity, Value | Login |
| Mar 31, 2024 | Fund Letters | Lansdowne Partners European Fund | LDO.MI | Leonardo S.p.A. | Industrials | Aerospace & Defense | Bull | Borsa Italiana | Aerospace, cybersecurity, Defense, electronics, geopolitical, Italy, NATO, turnaround, Value | Login |
| Mar 31, 2024 | Fund Letters | Lansdowne Partners European Fund | REL.L | RELX PLC | Communication Services | Professional Services | Bull | London Stock Exchange | analytics, GenAI, growth, Hard Currency Markets, Legal Services, professional services, risk management, technology integration | Login |
| Mar 31, 2024 | Fund Letters | Lansdowne Partners European Fund | EL.PA | EssilorLuxottica SA | Health Care | Health Care Equipment & Supplies | Bull | Euronext Paris | Aging demographics, Eye Care, Healthcare Equipment, innovation, Myopia Management, R&D Leadership, smart glasses, vertical integration | Login |
| TICKER | COMMENTARY |
|---|---|
| CPG.L | Strong Q4 and FY24 results and a robust guide for FY25 underpinned the market's ongoing re-assessment of Compass' medium-term growth algorithm. We continue to believe the business can grow organically, expand margins and provide positive returns. With the stock still trading at an attractive multiple of c24x, the shares are likely to be under-valued, suggesting continued market interest in the name. |
| EL.PA | Shares continued to perform well following strong feedback from Meta regarding the performance of its RayBan Meta smart glasses. Whilst relatively small as a share of group revenues for Essilor Luxottica (we estimate approximately1%), the innovation could be seen to be a representation of the medium-term growth strategy for the business. Additionally, share prices rose in Q4 following reports that Meta is seeking to build an approximate 4-5% stake in Essilor Luxottica, confirmation that the partnership with Meta is continuing to perform well. |
| LDO.MI | LDO delivered strong third quarter results with adjusted EBIT 14% ahead of consensus estimates. These results were due to strong growth in the underlying business as well as ahead-of-schedule deliver on their cost efficiency program. If not for a customer issue that was beyond their control, Leonardo confirmed that it would have upgraded FY guidance. The performance in the quarter was underpinned by not only a strong set of results but also increased credibility in the new management team. |
| SIKA.SW | Although third-quarter organic sales aligned with market expectations, Sika's profitability fell short as the business looks to invest in its end markets, aiming to capitalize on medium-term growth opportunities as market conditions stabilize and recover. To that end, we have been encouraged to note Sika's organic growth in the US has recovered to approximately 4-5% in 2H 2024 well ahead of end markets. Consequently, lending credence to the idea that these investments are enabling the business to continue to take market share and generate growth, albeit in the context of its end markets. Whilst short-term, recessionary end-markets and continued investments to prioritise medium term growth have kept earnings weak vs expectations, we are encouraged by the business' ongoing market share gains. |
| CAP.PA | Cap's third quarter results suffered due to another cut in 2024 organic growth guidance. Whilst broader pressures in Europe were well-known, a worse than expected recovery in the US and specific weakness in aerospace sector prompted the latest revision. Peer reporting and commentary from Accenture and the Indian IT majors (such as Infosys and TCS) underpin the view that the weakness in IT services demand has largely been cyclical, with consistent signs of green shoots beginning to emerge in the US. It is market view that Cap will benefit from similar trends in the US business. Heavy European, particularly French, exposure, could delay growth improvement compared to more US-focused peers, in the contrary the cyclical nature of end-market weakness, a resilient operating model (with flat to slightly rising margins during this recession cycle), and attractive valuations (shares trading at ~14x trough earnings), position the business well. As shareholders, we await a recovery in end markets. |
| LIN | Linde suffered modest earnings downgrades driven by persistent demand weakness in its key end markets as US manufacturing remained in recession throughout 2024. For context, Linde started the year with guidance for +8-11% EPS growth in constant FX, which has since been refined to +9-10%, a minimal downgrade compared to the top-end of the guidance range from the beginning of 2024. However, for a name where the market has become accustomed to consistent 'beats-and-raises', it could be seen that this modest downgrade has been enough to cause disappointment for share underperformance, especially in the fourth quarter. At a higher level, Linde remains a business generating double-digit EPS growth at a time when its end markets are in a prolonged and quite severe recession, this could indicate operating model. With shares now de-rated to just 25x PE, the shares under-valued for defensive, consistent, low-risk low double-digit TSR on offer through-cycle. We have used this temporary relative weakness in shares to add to our holding modestly. |
| ML.PA | In the most recent quarter, Michelin reported worse-than-expected volume weakness which catalysed a downgrade to FY24 earnings guidance. Away from the tactical aspect of the change in guidance, there is growing concern that the significant volume de-growth in the business (approximately 18% since 2019) is emblematic of changing competitive dynamics in its end markets (particularly with respect to the inflow of cheaper, low-end tyres from Asia). For such a well-established company, this could be seen to mask Michelin's industry leading price-mix contribution to earnings and hence limits through-cycle earnings growth vs our earlier expectations. Consequently, we have reduced our exposure for now. |
| Ticker | Put/Call | Amount Bought | Shares Bought | % Change | Weight % |
|---|---|---|---|---|---|
| No Recent Buys Data | |||||
| Ticker | Put/Call | Amount Sold | Shares Sold | % Change | Weight % | Status |
|---|---|---|---|---|---|---|
| No Recent Sells Data | ||||||
| Industry | Prev Quarter % | Current Quarter % | Change |
|---|---|---|---|
| No industry data available | |||